Why the study?
The Society of Cardiovascular Anesthesiologists and The Society of Thoracic Surgeons sought to improve the care, safety, and outcomes of adult patients undergoing cardiac surgery who are taking direct oral anticoagulants.
What is the optimal perioperative management of direct oral anticoagulants in adult patients undergoing cardiac surgery?
What is the optimal perioperative management of direct oral anticoagulants in adult patients undergoing cardiac surgery?
This joint consensus statement by the SCA and STS provides comprehensive guidance on managing DOACs perioperatively in cardiac surgery patients.
Answers are grounded in this paper and cite their sources.
Standardizes perioperative DOAC care in cardiac surgery; extends expert consensus where randomized evidence remains limited.
The Society of Cardiovascular Anesthesiologists (SCA) along with The Society of Thoracic Surgeons (STS) sought to improve the care of adult patients undergoing cardiac surgery who are taking direct oral anticoagulants (DOACs), such as factor Xa and direct thrombin inhibitors. To fulfill this, a systematic review of the literature on cessation of DOACs before cardiac surgery, options for monitoring DOACs, the need for bridging, reversal agents, and resuming the medications after surgery was performed. Additionally, an expert consensus around the management of these patients was completed. Summary statements were created using evidence and expert consensus to guide care of patients in each of these domains, with the ultimate goal to enhance patient safety and outcomes.
No takes yet. Share an insight, caveat, or question.
Budd et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: